Don't think so, they would have had a new supplier lined up already and wouldn't have needed the TH as they would have had the announcement ready. Go Medical terminated, not Admedus.
It definitely wasn't expected on the Admedus end, otherwise they would have been able to mitigate the risk and been on top of it. The new head of Infusions seems like a bit of a Muppet, if you want a better deal have a competitive offer from another supplier. Probably wanted to make a name for himself and now he is in hot water.
Don't think so, they would have had a new supplier lined up...
-
- There are more pages in this discussion • 130 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.63 |
Change
-0.070(0.45%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $16.00 | $16.01 | $15.49 | $221.7K | 14.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | $15.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.66 | 4 | 2 |
View Market Depth
| Last trade - 14.14pm 25/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |